Drzewiecka Dominika, Shashkov Alexander S, Arbatsky Nikolay P, Knirel Yuriy A
Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź,90-237 Łódź,Poland.
N. D. Zelinsky Institute of Organic Chemistry,Russian Academy of Sciences, 119991 Moscow,Russia.
Microbiology (Reading). 2016 May;162(5):789-797. doi: 10.1099/mic.0.000274. Epub 2016 Mar 9.
A hospitalized 73-year-old woman was infected with a Proteus mirabilis strain, 12 B-r, isolated from the place of injection of a blood catheter. Another strain, 12 B-k, recognized as Proteus genomospecies 5 or 6, was isolated from the patient's faeces, which was an example of a nosocomial infection rather than an auto-infection. Serological investigation using ELISA and Western blotting showed that strain 12 B-k from faeces belonged to the Proteus O2 serogroup. Strain 12 B-r from the wound displayed cross-reactions with several Proteus O serogroups due to common epitopes on the core or O-specific parts of the lipopolysaccharide. Studies of the isolated 12 B-r O-specific polysaccharide by NMR spectroscopy revealed its close structural similarity to that of Proteus O8. The only difference in 12 B-r was the presence of an additional GlcNAc-linked phosphoethanolamine residue, which creates a putative epitope responsible for the cross-reactivity with Pt. mirabilis O16. The new O-antigen form could appear as a result of adaptation of the bacterium to a changing environment. On the basis of the data obtained, we suggest division of the O8 serogroup into two subgroups: O8a for strains of various Proteus species that have been previously classified into the O8 serogroup, and O8a,b for Pt. mirabilis 12 B-r, where 'a' is a common epitope and 'b' is a phosphoethanolamine-associated epitope. These findings further confirm serological and structural heterogeneity of O antigens of Proteus strains isolated lately from patients in Poland.
一名73岁的住院女性感染了从血导管注射部位分离出的奇异变形杆菌菌株12 B-r。另一种菌株12 B-k,被认定为变形杆菌基因组种5或6,从患者粪便中分离得到,这是一例医院感染而非自身感染的病例。使用酶联免疫吸附测定(ELISA)和蛋白质印迹法进行的血清学调查表明,来自粪便的12 B-k菌株属于变形杆菌O2血清群。来自伤口的12 B-r菌株由于脂多糖核心或O-特异性部分上的共同表位,与几种变形杆菌O血清群发生交叉反应。通过核磁共振光谱对分离出的12 B-r O-特异性多糖进行的研究显示,其结构与变形杆菌O8的结构非常相似。12 B-r的唯一区别在于存在一个额外的与N-乙酰葡糖胺相连的磷酸乙醇胺残基,该残基产生了一个假定的表位,负责与奇异变形杆菌O16的交叉反应。新的O抗原形式可能是细菌适应不断变化的环境的结果。基于所获得的数据,我们建议将O8血清群分为两个亚群:O8a用于先前已归类为O8血清群的各种变形杆菌菌株,O8a,b用于奇异变形杆菌12 B-r,其中“a”是共同表位,“b”是与磷酸乙醇胺相关的表位。这些发现进一步证实了最近从波兰患者中分离出的变形杆菌菌株O抗原的血清学和结构异质性。